幹細胞治療の世界市場:自己幹細胞治療、アロジェネイック幹細胞治療...市場調査レポートについてご紹介

【英文タイトル】Stem Cell Therapy - Global Market Outlook (2015-2022)

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Application Analysis
3.8 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Stem Cell Therapy Market, By Treatment
5.1 Introduction
5.2 Autologous stem cell therapy
5.2.1 CNS Diseases
5.2.2 Wounds and Injuries
5.2.3 CVS Diseases
5.2.4 Musculoskeletal Disorders
5.2.5 GIT Diseases
5.2.6 Other Diseases
5.3 Allogeneic stem cell therapy
5.3.1 CNS Diseases
5.3.2 Musculoskeletal Disorders
5.3.3 Wounds and Injuries
5.3.4 GIT diseases
5.3.5 Metabolic Diseases
5.3.6 Immune System Diseases
5.3.7 Eye Diseases
5.3.8 CVS Diseases
5.3.9 Other Diseases

6 Global Stem Cell Therapy Market, By End User
6.1 Introduction
6.2 Hospitals
6.3 Ambulatory Surgical centers

7 Global Stem Cell Therapy Market, By Application
7.1 Introduction
7.2 Cardiovascular diseases
7.3 Eye diseases
7.4 Metabolic diseases
7.5 Musculoskeletal disorders
7.6 Gastro intestine diseases
7.7 Central Nervous System diseases
7.8 Immune system diseases
7.9 Wounds and injuries
8.10 Other diseases

8 Global Stem Cell Therapy Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Aastrom Biosciences Inc.
10.2 Cellular Dynamics International Inc.
10.3 ReNeuron Group plc
10.4 Roslin Cells limited
10.5 Advanced Cell Technologies Inc.
10.6 Cytori Therapeutics Inc.
10.7 Celgene Corporation
10.8 Gamida Cell Ltd.
10.9 International Stem Cell Corporation
10.10 Mesoblast Ltd.
10.11 Pluristem Therapeutics Inc.
10.12 Fibrocell Science Inc.
10.13 Stemcells Inc.
10.14 Regeneus Ltd
10.15 Athersys Inc.

List of Tables
1 Global Stem Cell Therapy Market Outlook, By Region (2013-2022) ($MN)
2 Global Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
3 Global Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
4 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
5 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
6 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
7 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
8 Global Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
9 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
10 Global Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
11 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
12 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
13 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
14 Global Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
15 Global Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
16 Global Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
17 Global Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
18 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
19 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
20 Global Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
21 Global Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
22 Global Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
23 Global Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
24 Global Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
25 Global Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
26 Global Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
27 Global Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
28 Global Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
29 Global Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
30 Global Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
31 Global Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
32 Global Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
33 Global Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
34 North America Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
35 North America Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
36 North America Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
37 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
38 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
39 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
40 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
41 North America Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
42 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
43 North America Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
44 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
45 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
46 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
47 North America Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
48 North America Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
49 North America Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
50 North America Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
51 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
52 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
53 North America Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
54 North America Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
55 North America Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
56 North America Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
57 North America Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
58 North America Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
59 North America Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
60 North America Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
61 North America Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
62 North America Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
63 North America Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
64 North America Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
65 North America Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
66 North America Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
67 Europe Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
68 Europe Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
69 Europe Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
70 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
71 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
72 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
73 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
74 Europe Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
75 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
76 Europe Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
77 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
78 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
79 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
80 Europe Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
81 Europe Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
82 Europe Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
83 Europe Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
84 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
85 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
86 Europe Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
87 Europe Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
88 Europe Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
89 Europe Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
90 Europe Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
91 Europe Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
92 Europe Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
93 Europe Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
94 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
95 Europe Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
96 Europe Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
97 Europe Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
98 Europe Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
99 Europe Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
100 Asia Pacific Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
101 Asia Pacific Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
102 Asia Pacific Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
103 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
104 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
105 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
106 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
107 Asia Pacific Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
108 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
109 Asia Pacific Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
110 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
111 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
112 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
113 Asia Pacific Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
114 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
115 Asia Pacific Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
116 Asia Pacific Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
117 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
118 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
119 Asia Pacific Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
120 Asia Pacific Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
121 Asia Pacific Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
122 Asia Pacific Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
123 Asia Pacific Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
124 Asia Pacific Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
125 Asia Pacific Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
126 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
127 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
128 Asia Pacific Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
129 Asia Pacific Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
130 Asia Pacific Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
131 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
132 Asia Pacific Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
133 RoW Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
134 RoW Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
135 RoW Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
136 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
137 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
138 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
139 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
140 RoW Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
141 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
142 RoW Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
143 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
144 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
145 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
146 RoW Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
147 RoW Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
148 RoW Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
149 RoW Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
150 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
151 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
152 RoW Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
153 RoW Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
154 RoW Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
155 RoW Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
156 RoW Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
157 RoW Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
158 RoW Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
159 RoW Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
160 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
161 RoW Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
162 RoW Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
163 RoW Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
164 RoW Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
165 RoW Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)


【レポート販売概要】

■ タイトル:幹細胞治療の世界市場:自己幹細胞治療、アロジェネイック幹細胞治療
■ 英文:Stem Cell Therapy - Global Market Outlook (2015-2022)
■ 発行日:2016年5月11日
■ 調査会社:Stratistics MRC
■ 商品コード:SMRC60799
■ 調査対象地域:グローバル
  • 世界の体外診断(IVD)市場
    The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion w …
  • 世界の神経診断市場:製品別(診断および画像システム(MRI、超音波)、臨床検査(PCR、NGS)、試薬および消耗品)、疾患病理学別(てんかん、脳卒中)、エンドユーザー別、地域別
    “The global neurodiagnostics market is projected to grow at a CAGR of 7.3% during the forecast period.” The global neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%. The demand for neurodiagnostic products is expected to grow due to the increasing prevalence of neurological disorders & diseases. The neurodiagnostics market is segme …
  • スマート照明の世界市場:蛍光ランプ、LEDランプ、HIDランプ
    Smart lighting is an advanced technology in lighting that makes use of intelligent lighting control systems to manage the illumination of a particular area. Smart lighting market is growing at a phenomenal rate and main drivers for this growth are energy efficiency, development in electronics and sensor technology, phase out of incandescent lamps, favorable government policies and evolution of nov …
  • 中東(GCC)の建設産業における投資分析:契約、投資、プロジェクト、原材料貿易、機会分析
    As per IMF, the GCC population is projected to grow at a CAGR of 2.80% from 2015 to 2020 to reach 53.41 million. An expanding population is expected to urge higher demand in residential, commercial, retail, hospitality, healthcare, and infrastructure sectors across the GCC region. GCC countries are focusing on economic diversification as oil prices are more versatile from the last two years. GCC c …
  • PaaSの世界市場2015-2019
    PaaS is a category of cloud computing services that provides application development platform with a development tool hosted in the cloud and accessed through a web browser. The cloud resources are deployed and managed by cloud service providers while end-users have the liberty to use the service on a pay-per-use basis. With the PaaS solution, developers can build web applications without installi …
  • Endotoxemia:グローバル臨床試験レビューH2, 2013
    Endotoxemia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Endotoxemia Global Clinical Trials Review, H2, 2013" provides data on the Endotoxemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endotoxemia. It includes an overview of the trial numbers and their recruitment status as per the site of …
  • バルク食品成分の世界市場動向・予測(~2021)
    The global bulk food ingredients market was valued at USD 369.51 Billion in 2015. It is projected to reach USD 472.10 Billion by 2021, at a CAGR of 4.2% from 2016 to 2021. The market is driven by factors such as increased demand for snacks & spreads, ready meals, and infant formulas due to changing consumer preferences. Furthermore, factors such as increasing disposable incomes and rapid urbanizat …
  • 世界のVoLTE市場:機会、課題、戦略、予測
    VoLTE (Voice over LTE) technology allows a voice call to be placed over an LTE network, enabling operators to reduce reliance on legacy circuit-switched networks. Powered by IMS (IP Multimedia Subsystem) architecture, VoLTE brings a host of benefits to mobile operators ranging from the ability to refarm legacy 2G and 3G spectrum to offering their subscribers a differentiated service experience thr …
  • 肝腎症候群(Hepatorenal Syndrome):世界の治験レビュー(2015年上半期版)
    Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Hepatorenal Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatorenal Syndrome. It includes an overview of the trial numbers and their r …
  • 移動ロボットの世界市場
    Mobile robots refers to robotic systems that are capable of moving and performing various tasks in several applications such as defense, marine, manufacturing, agriculture & forestry, healthcare facilities, educational institutions, homes, and others. These robots also help businesses to increase their return on investment (ROI) and reduce the costs significantly, by saving the time and costs asso …
  • 自動車用アルミニウム材料の世界市場
    About Automotive Aluminum market Aluminum and its alloys have unique properties such as lightweight, high tensile strength, and high corrosion resistance, allowing it to replace steel that has conventionally been used to make an automobile's body and its components. It offers the safest, fastest, cost-effective, and an environmentally friendly way to boost fuel economy, reduce emissions, and incre …
  • グローバル製薬産業サーベイ(2013-2014):市場動向、購買戦略
    Why was the report written? This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global pharmaceutical industry executives; it provides data and analysis on buyer expenditure, procurement, and developments within the global pharmaceutical industry. The report includes key topics such as global pharmaceutical industry buyer expenditure and procuremen …
  • グレインミル製品の世界市場:製品種類別(小麦、米、その他)、流通経路別(スーパーマーケット/ハイパーマーケット、食料品店、オンラインストア)
    Flour is mainly obtained by grinding wheat, maize, rice, and other cereals. Wheat is the grain most commonly used to make flour, accounting nearly 84.5% of the total content, followed by maize (a staple in the Americas) and rice. Wheat is the main ingredient used in the production of bread, which is a staple food for many cultures. Flour contains a high proportion of starch, which is a subset of c …
  • 世界の医療産業におけるふっ素ポリマ(Fluoropolymer)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Fluoropolymer market in the Healthcare industry to grow at a CAGR of 7.57 percent over the period 2012-2016. One of the key factors contributing to this market growth is the unique properties of fluoropolymer. The Global Fluoropolymer market in the Healthcare industry has also been witnessing the trend of increasing mergers and acquisitions. However, the av …
  • 世界のバイオプラスチック・パッケージング市場:Global Bioplastic Packaging Market 2014-2018
    TechNavio's analysts forecast the Global Bioplastic Packaging market to grow at a CAGR of 19.85 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing concern for environmentally-friendly packaging. The Global Bioplastic Packaging market has also been witnessing the increasing demand from emerging countries. However, the premium pricing of biopl …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。